Table 4 Relationship between s-ECSA-2-Abs and the clinicopathological variables in patients with esophageal SCC.
From: Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma
Variables (No. of patients) | Â | No. of patients with s-ECSA-2-Abs (positive rate %) | P-value |
|---|---|---|---|
Gender | Male (63) | 10 (16) | >0.9999 |
| Â | Female (9) | 1 (11) | Â |
Age | <65 years (31) | 6 (19) | 0.5132 |
|  | ≥65 years (41) | 5 (12) |  |
Tumor location | Upper (13) | 1 (8) | 0.6757 |
| Â | Lower (59) | 10 (17) | Â |
Tumor size | <50 mm (39) | 4 (10) | 0.3245 |
|  | ≥50 mm (33) | 7 (21) |  |
Tumor depth | T1, T2 (35) | 3 (9) | 0.1906 |
| Â | T3, T4 (37) | 8 (22) | Â |
N factor | N0 (25) | 1 (4) | 0.0836 |
| Â | N1 (47) | 10 (21) | Â |
M factor | M0 (61) | 8 (13) | 0.3562 |
| Â | M1 (11) | 3 (27) | Â |
Stage | I, II (37) | 3 (8) | 0.1073 |
| Â | III, IV (35) | 8 (35) | Â |